Press Release
Category Added in a WPeMatico Campaign
-
Cytactic Welcomes Cybercrime Pioneer Shawn J. Chen to Advisory Board Following Strategic Investment
Former Federal Prosecutor, Cybercrime Trailblazer, and Stripe Executive Joins Cytactic to Help Shape the Future of Cyber Incident Response Management…
Read More » -
Every Booth Records Activity. Captello Proves Revenue.
The Next Generation of Captello Is Here: Bringing lead capture, meetings, activations, and event revenue intelligence in The Only Event-to-Revenue…
Read More » -
Evogene Schedules Second Quarter 2026 Financial Results Release
Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 /PRNewswire/ — Evogene Ltd.…
Read More » -
Lightspeed Announces First Quarter 2027 Financial Results
First quarter revenue of $322.7 million and organic1 revenue growth of 17%, exceeded outlook Gross profit of $138.6 million and organic1…
Read More » -
LUCY x TheBurntPeanut. Official.
Partnership embeds LUCY directly into the Peanut-verse, the fully custom 3D universe built around TheBurntPeanut’s character LAS VEGAS, July 30,…
Read More » -
TriNet Announces Second Quarter 2026 Results & Raises FY26 Earnings Guidance
50% Growth in GAAP Earnings per Diluted Share to $1.15 for the Second Quarter 2026 35% Growth in Adjusted Net…
Read More » -
Webull Adds Benzinga’s Premium Newsfeed, Press Releases and Economic Calendar
Real-time equities news, press releases and economic data now power Webull’s trading platform DETROIT, July 30, 2026 /PRNewswire/ — Benzinga,…
Read More » -
Daqo New Energy Issues Its 2025 Environmental, Social and Governance (ESG) Report
SHANGHAI, July 30, 2026 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy,” the “Company” or “we”), a leading…
Read More » -
Announcing Trimble Dimensions 2026 User Conference and Offsite Expo
Annual conference returns to Las Vegas to solve customer challenges, accelerate AI innovation and redefine the future of work across…
Read More » -
CREATE Medicines Receives Approval to Initiate First-in-Human Phase 1/2 Clinical Trial of In Vivo CAR-T Candidate CRT-402 for Autoimmune Diseases
Australian HREC approval clears the initiation of CREATE’s first-in-human Phase 1/2 study evaluating CRT-402 in patients with systemic lupus erythematosus…
Read More »